Last 0.43 MYR
Change Today 0.00 / 0.00%
Volume 0.0
STEM On Other Exchanges
Symbol
Exchange
Kuala Lumpur
As of 1:30 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

stemlife bhd (STEM) Snapshot

Open
0.44
Previous Close
0.43
Day High
0.44
Day Low
0.43
52 Week High
08/13/14 - 0.57
52 Week Low
12/1/14 - 0.40
Market Cap
106.4M
Average Volume 10 Days
123.3K
EPS TTM
0.0042
Shares Outstanding
247.5M
EX-Date
06/9/14
P/E TM
102.4x
Dividend
0.03
Dividend Yield
6.98%
Current Stock Chart for STEMLIFE BHD (STEM)

Related News

No related news articles were found.

stemlife bhd (STEM) Related Businessweek News

No Related Businessweek News Found

stemlife bhd (STEM) Details

Stemlife Berhad, an investment holding company, operates as a cell banking and therapeutics company in Malaysia. The company is involved in the provision of stem cell therapy and stem cell consultancy services; collection, testing, processing, and preservation of umbilical cord blood stem cells; and harvesting, testing, processing, and preservation of peripheral blood stem cells. It also provides logistic services for umbilical cord blood stem cells and peripheral blood stem cells. Stemlife Berhad was founded in 2001 and is headquartered in Kuala Lumpur, Malaysia.

Founded in 2001

stemlife bhd (STEM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

stemlife bhd (STEM) Key Developments

Stemlife Berhad Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Stemlife Berhad announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenue of MYR 4,170,000 against MYR 4,460,000 a year ago. This id due to lower processing revenue arising from a decrease in new signed-up cases of 7%. Profit from operations was MYR 284,000 against MYR 577,000 a year ago. Profit before taxation was MYR 182,000 against MYR 674,000 a year ago. Profit attributable to ordinary equity holders of the parent was MYR 119,000 or 0.05 sen per basic and diluted share against MYR 603,000 or 0.24 sen per basic and diluted share a year ago. For the nine months, the company reported revenue of MYR 11,903,000 against MYR 13,010,000 a year ago. The decrease is mainly due to lower processing fee revenue in 2014, arising from a decrease in new signed-up cases of 9%. Profit from operations was MYR 230,000 against MYR 2,090,000 a year ago. Profit before taxation was MYR 81,000 against MYR 2,339,000 a year ago. Loss attributable to ordinary equity holders of the parent was MYR 108,000 or 0.04 sen per basic and diluted share against profit of MYR 2,149,000 or 0.87 sen per basic and diluted share a year ago. Net cash flow from operating activities was MYR 940,000 against MYR 6,520,000 a year ago. Purchase of properties, plants and equipments was MYR 172,000 against MYR 1,093,000 a year ago.

Stemlife Berhad Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Stemlife Berhad reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenue of MYR 3,880,000 against MYR 4,171,000 a year ago. Loss from operations was MYR 284,000 against profit from operations of MYR 809,000 a year ago. Loss before tax was MYR 344,000 against profit before tax of MYR 851,000 a year ago. Loss attributable to ordinary equity holders of the parent was MYR 407,000 against profit attributable to ordinary equity holders of the parent of MYR 789,000 a year ago. Basic and diluted loss per share was 0.16 sen against basic and diluted earnings per share of 0.32 sen a year ago. The group recorded a decrease of 7% in revenue. This is due to lower processing revenue showing a decrease of 19% against second quarter of 2013 arising from the lower number of new signed-up cases. However, storage income shows an increase of 8% compared to the corresponding quarter. Net loss after taxation was MYR 407,000 compared to a profit of MYR 789,000 registered in the corresponding quarter, a decrease of 151%. This is mainly due to higher administrative expenses incurred and lower share of results from Thai Stemlife. For the six months, the company reported revenue of MYR 7,734,000 against MYR 8,549,000 a year ago. Loss from operations was MYR 55,000 against profit from operations of MYR 1,512,000 a year ago. Loss before tax was MYR 102,000 against profit before tax of MYR 1,665,000 a year ago. Loss attributable to ordinary equity holders of the parent was MYR 227,000 against profit attributable to ordinary equity holders of the parent of MYR 1,546,000 a year ago. Basic and diluted loss per share was 0.09 sen against basic and diluted earnings per share of 0.62 sen a year ago. Net cash used in operating activities was MYR 801,000 against net cash flow from operating activities of MYR 4,318,000 a year ago. Purchase of properties, plants and equipments were MYR 156,000 against MYR 502,000 a year ago. The decrease is mainly due to lower processing fee revenue in 2014, a decrease of 23% but with slightly better annual storage fee income. The group's loss after taxation was MYR 227,000 against profit after taxation of MYR 1.55 million for the same period of 2013. This decrease was resulted from the lower processing fee revenue, higher administrative expenses and loss sharing of the associated company.

Stemlife Berhad Announces Retirement of Lim Jit Soon as a Director, Effective May 27, 2014

Stemlife Berhad announced that Mr. Lim Jit Soon did not seek for re-election at the Annual General Meeting. Therefore, he retired as a Director of the company at the conclusion of the AGM held on 27 May 2014. Mr. Lim Jit Soon remains as the Chief Financial Officer of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STEM:MK 0.43 MYR 0.00

STEM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for STEM.
View Industry Companies
 

Industry Analysis

STEM

Industry Average

Valuation STEM Industry Range
Price/Earnings 100.0x
Price/Sales 5.9x
Price/Book 3.6x
Price/Cash Flow 97.0x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STEMLIFE BHD, please visit www.stemlife.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.